SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-000752
Filing Date
2020-01-17
Accepted
2020-01-17 17:00:42
Documents
7
Period of Report
2020-01-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31357
2 ex99-1.htm EX-99.1 15251
3 ex99-1_001.jpg GRAPHIC 270494
4 ex99-1_002.jpg GRAPHIC 449542
5 ex99-1_003.jpg GRAPHIC 477938
6 ex99-1_004.jpg GRAPHIC 379529
7 ex99-1_005.jpg GRAPHIC 213211
  Complete submission text file 0001493152-20-000752.txt   2514262
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 20534202
SIC: 2835 In Vitro & In Vivo Diagnostic Substances